Eli Lilly Expands Gene Therapy Portfolio to Eye Care with $475M MeiraGTx Deal
Eli Lilly bets big on the future of gene therapy for vision restoration. Eli Lilly is making another bold move…
FDA Grants Priority Review to Idebenone for Leber Hereditary Optic Neuropathy
A rare disease, a rare chance. FDA fast-tracks idebenone for LHON. The U.S. Food and Drug Administration (FDA) doesn’t hand…
latest posts
